Division of Pulmonary, Critical Care and Sleep Medicine, Department of Medicine, University of California San Diego (UCSD), 9300 Campus Point Drive #7381, La Jolla, CA, 92037, USA.
Altman Clinical and Translational Research Institute, University of California San Diego, La Jolla, CA, USA.
Sleep Breath. 2023 May;27(2):553-560. doi: 10.1007/s11325-022-02646-7. Epub 2022 May 31.
PURPOSE: Sleep disordered breathing in decompensated heart failure has physiological consequences (e.g., intermittent hypoxemia) that may predispose to subclinical myocardial injury, yet a temporal relationship between sleep apnea and troponin elevation has not been established. METHODS: We assessed the feasibility of performing respiratory polygraphy and measuring overnight high-sensitivity cardiac troponin T change in adults admitted to the hospital with acutely decompensated heart failure. Repeat sleep apnea tests (SATs) were performed to determine response to optimal medical heart failure therapy. Multivariable logistic regression was used to identify associations between absolute overnight troponin change and sleep apnea characteristics. RESULTS: Among the 19 subjects with acutely decompensated heart failure, 92% of SATs demonstrated sleep disordered breathing (apnea-hypopnea index [AHI] > 5 events/h). For those with repeat SATs, AHI increased in 67% despite medical management of heart failure. Overnight troponin increase was associated with moderate to severe sleep apnea (vs. no to mild sleep apnea, odds ratio (OR = 18.4 [1.51-224.18]), central apnea index (OR = 1.11 [1.01-1.22]), and predominantly central sleep apnea (vs. obstructive, OR = 22.9 [1.29-406.32]). CONCLUSIONS: Sleep apnea severity and a central apnea pattern may be associated with myocardial injury. Respiratory polygraphy with serial biomarker assessment is feasible in this population, and combining this approach with interventions (e.g., positive airway pressure) may help establish if a link exists between sleep apnea and subclinical myocardial injury.
目的:失代偿性心力衰竭中的睡眠呼吸障碍具有生理后果(例如间歇性低氧血症),可能易导致亚临床心肌损伤,但尚未确定睡眠呼吸暂停与肌钙蛋白升高之间的时间关系。
方法:我们评估了在因急性失代偿性心力衰竭住院的成人中进行呼吸描记术和测量 overnight high-sensitivity cardiac troponin T 变化的可行性。进行重复睡眠呼吸暂停测试(SAT)以确定对最佳心力衰竭药物治疗的反应。多变量逻辑回归用于确定 overnight troponin 变化与睡眠呼吸暂停特征之间的关联。
结果:在 19 例急性失代偿性心力衰竭患者中,92%的 SAT 显示存在睡眠呼吸障碍(呼吸暂停低通气指数[AHI]>5 次/小时)。对于那些进行重复 SAT 的患者,尽管心力衰竭的药物治疗,AHI 仍增加了 67%。 overnight troponin 增加与中重度睡眠呼吸暂停(而非无至轻度睡眠呼吸暂停)、中枢性呼吸暂停指数(OR=18.4[1.51-224.18])和主要为中枢性睡眠呼吸暂停(而非阻塞性,OR=22.9[1.29-406.32])相关。
结论:睡眠呼吸暂停的严重程度和中枢性呼吸暂停模式可能与心肌损伤有关。在该人群中进行呼吸描记术和连续生物标志物评估是可行的,并且结合这种方法和干预措施(例如正压通气)可能有助于确定睡眠呼吸暂停与亚临床心肌损伤之间是否存在联系。
Am J Respir Crit Care Med. 2016-3-1
J Clin Sleep Med. 2021-7-1